Glycemic Control in a Patient with Type 2 Diabetes and Advanced CKD
A 68-year-old man with type 2 diabetes for 15 years, stage 4 chronic kidney disease (eGFR 22 mL/min/1.73 m²), hypertension and obesity (BMI 32) is referred for MNT. Current medications: metformin 1 g twice daily, gliclazide 80 mg twice daily, ramipril 5 mg, atorvastatin 20 mg. HbA1c 7.9%, potassium 5.4 mmol/L, phosphate 1.6 mmol/L, bicarbonate 20 mmol/L, albumin 36 g/L. He reports poor appetite, early satiety, and frequent hypoglycemic episodes in the afternoon. He follows a 'diabetic diet' high in whole grains and fruit and avoids protein because 'the kidney doctor said protein is bad.' He is 82 kg.
1. Identify the medication-related and nutrition-related issues contributing to his hypoglycemia and formulate a prioritized plan.
Read the worked answer
Medication issues:
- Metformin is contraindicated at eGFR <30 due to lactic acidosis risk; it should be stopped. This is a safety issue to flag to the prescriber.
- Gliclazide is a sulfonylurea; its active metabolites accumulate in CKD, causing prolonged hypoglycemia. The afternoon hypos are consistent with this. Dose reduction or switch to a safer agent (e.g., a DPP-4 inhibitor with renal dose adjustment, or insulin with careful titration) should be discussed with the physician.
Nutrition issues:
- His 'diabetic diet' is high in whole grains and fruit, which may be contributing to glycemic variability and hyperkalemia/hyperphosphatemia in CKD.
- He avoids protein unnecessarily; at stage 4 CKD, protein should be not severely restricted - typically ~0.8 g/kg/day (about 65 g/day for 82 kg) unless dialysis is imminent. Adequate protein prevents malnutrition.
- Poor appetite and early satiety suggest uremia and possibly gastroparesis; small frequent meals are appropriate.
Priorities:
- Communicate metformin discontinuation and sulfonylurea review urgently.
- Address hypoglycemia first - it is immediately dangerous.
- Adjust diet for CKD: limit high-potassium foods (bananas, oranges, potatoes without leaching, tomatoes), limit phosphate additives, moderate whole grains, and ensure adequate but not excessive protein.
- Monitor potassium, phosphate, bicarbonate and albumin; consider renal dietitian co-management.
2. He asks whether he should follow a very low-protein diet to 'save his kidneys.' How do you respond, and what is the evidence?
Read the worked answer
A very low-protein diet (e.g., 0.3–0.4 g/kg/day) is not routinely recommended and carries a high risk of protein-energy wasting in a patient who already has poor appetite and low albumin. Evidence (e.g., systematic reviews and the modified diet in renal disease trial) shows that while lower protein intake may slow progression modestly, the benefit is small and the risk of malnutrition is real. Current guidance (KDIGO) recommends 0.8 g/kg/day for non-dialyzed CKD, with avoidance of high biological value excess only if indicated.
For this patient, 82 kg × 0.8 = ~65 g/day protein. Given obesity, some clinicians use adjusted body weight, which would lower the target slightly - but the key message is 'adequate, not deficient.' Emphasize plant-based proteins in moderation, control of potassium and phosphate additives, and adequate energy intake (~30 kcal/kg) to prevent catabolism.
Explain that the priority is preserving muscle mass and nutritional status while managing electrolytes and blood pressure.
3. His potassium is 5.4 mmol/L. Outline your dietary approach and when you would escalate.
Read the worked answer
Dietary approach for hyperkalemia in CKD:
- Review intake of high-potassium foods: bananas, oranges, potatoes, tomatoes, spinach, beans, salt substitutes (potassium chloride), and fruit juices.
- Teach leaching of potatoes and other root vegetables (soak in water, discard water) and portion control rather than elimination.
- Avoid potassium-based salt substitutes - a common hidden source.
- Review medications that raise potassium: ramipril (ACE inhibitor) - do not stop without physician input, but flag it.
- Ensure adequate energy so the patient is not catabolizing muscle (which releases potassium).
- Check for constipation - poor bowel function impairs potassium excretion; encourage fiber and fluids as appropriate.
Escalation: Potassium 5.4 is moderately elevated. Escalate to the physician if >5.5–6.0, if there are ECG changes, or if it rises despite dietary measures. Do not attempt to manage >6.0 with diet alone. Coordinate with nephrology and review the ACE inhibitor dose and possible potassium binders.